PIK3CA and prostate carcinoma: Firstly, a previous study has revealed that increased expression of HDACs and activation of PI3K/AKT‐mTORC1 pathway commonly occur in prostate cancer (Ellis et al, 2013), suggesting that both are highly relevant to prostate cancer.